Variable Pretreatment Posttreatment P GFR (mL/min) 115±18 102±14 NS

Slides:

Advertisements

Similar presentations

The reading is 7.38 mm. The reading is 7.72 mm.

Advertisements

Echocardiographic Changes in Patients with Stage 3-5 Chronic Kidney Disease and Left Ventricular Diastolic Dysfunction Cardiorenal Med 2014;4:

The LIVES Sub-analysis

RIFLE criteria for acute kidney injury

Section 3: CKD, CVD and mortality

A comparison of normal cardiac anatomy (A) and the pathology of hypertrophic cardiomyopathy (B). Hypertrophic cardiomyopathy causes cardiomegaly (570 g;

The MDRD Study.

Sensitivity and specificity for various renal-related diagnoses (values are compared with an eGFR

End point Patients >75 y with renal insufficiency

Atorvastatin 20 mg (n=25 lesions) Atorvastatin 5 mg (n=25 lesions)

Bhandari et al. Am J Nephrol 2017;45: (DOI: / )

ASPN member survey on participation in contact/collision sports by children with a single normal kidney Response n/135 (%) Would not allow participation.

considering further dose(s)

Mean eGFR among survivors after CABG surgery vs all-cause deaths

Figure 1 The burden of chronic kidney disease (CKD)

TNT post hoc analysis: Improvement between baseline and final visit in estimated GFR by treatment group End point 10-mg atorvastatin 80-mg atorvastatin.

Figure 1 Acute kidney injury and chronic kidney disease

Creatinine clearance in cases and controls

Figure 5 Potential roles of phosphate and fibroblast growth factor 23 (FGF-23) in the development of cardiovascular disease in patients with chronic kidney.

Alan G. Japp et al. JACC 2016;67: Differentiation of Athlete’s Heart From Early DCM by Myocardial Deformation Imaging Two-dimensional speckle.

Patient with 5/10 concordant, bilateral, occipital head, CVJ, and upper neck pain. Patient with 5/10 concordant, bilateral, occipital head, CVJ, and upper.

End point Fenoldopam, n (%) Dopamine, n (%) p

CREATE: Baseline values

Juan J. Russo et al. JACC 2019;73:

Your Kidneys May Outlive You

Volume 72, Issue 10, Pages (November 2007)

Left ventricular hypertrophy in renal failure

Predictors of disease progression in patients with CKD

Adjusted relative risk for developing end-stage renal disease (ESRD) associated with blood-pressure level BP level (mm Hg) Adjusted relative risk 95%

Anemia as a risk factor for chronic kidney disease

D. Batlle, P. Ramadugu, M.J. Soler Kidney International

Manjula Kurella Tamura, Kristine Yaffe Kidney International

Statins and other agents for vascular inflammation

Volume 69, Issue 4, Pages (February 2006)

Kidney Disease Among African Americans: A Population Perspective

Variable WKY C WKY H WKY R WKY H+R SHR C SHR H SHR R SHR H+R

Bar chart of systolic function in healthy individuals, HCM LVH− patients and HCM LVH+ patients. GLS was significantly worse in the HCM LVH+ patients compared.

Risk factor Treatment GFR at baseline GFR at 5 years p Cadaveric donor

Risks and Outcomes of Acute Kidney Injury Requiring Dialysis After Cardiac Transplantation Janet M. Boyle, MD, Soundous Moualla, MD, Susana Arrigain,

Classification by HtTKV0 and age at HtTKV0 predicts the change in eGFR over time in class 1 patients. Classification by HtTKV0 and age at HtTKV0 predicts.

Martin K. Kuhlmann, Martina Heckmann, Werner Riegel, Hans Köhler

Prevalence and Severity of Renal Disease in Familial Dysautonomia

Drug Dose Adjustments in Patients With Renal Impairment

Nowak et al. Am J Nephrol 2016;44: (DOI: / )

Cumulative survival without events during 1 year in patients with preserved systolic function (left ventricular ejection fraction (LVEF) >40%) and with.

Incidence of contrast-induced nephropathy in patients with CKD, normal kidney function and all patients. Incidence of contrast-induced nephropathy in patients.

Patient selection. *This category included 10 patients with suspected tachyarrhythmia, 9 treated for cancer with cardiotoxic cytostatics and/or transthoracic.

Prevalence of the clinical, ECG and echocardiographic signs in the group with moderate and severe IVST increase in the THAOS population with echocardiography.

Examples of association between CMR features and abnormal Q waves.

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

Representative transaxial thin computed tomography (CT) sections at mid, mid-low, and low levels of the heart from a control subject (left) showing normal.

Jose R. Garcia et al. BTS 2017;2:

Average left ventricular ejection fraction (LVEF) values during the 1 year of observation in patients with preserved systolic function (LVEF >40%) and.

Volume 66, Issue 2, Pages (August 2004)

Giuseppe Remuzzi, Carlos Chiurchiu, Piero Ruggenenti

Mild renal insufficiency is associated with reduced coronary flow in patients with non- obstructive coronary artery disease A.R. Chade, D. Brosh, S.T.

Calcifications in autosomal dominant polycystic kidneys.

The various causes of electrocardiographic ST segment depression.

Ann M. O'Hare, MA, MD American Journal of Kidney Diseases

Оюутны эрдэм шинжилгээний хурлын зорилго:

The development of regional ventricular dysfunction as measured by regional wall motion abnormalities (RWMA; abnormal regions) was associated with a greater.

Relationship between time from diagnosis of type 2 diabetes to renal biopsy and the proportion of biopsies with any diabetic nephropathy (DN) and any non-diabetic.

A, The axial HRCT image of the right temporal bone in case 1 shows an erosion in the posterior temporal bone wall (arrow). A, The axial HRCT image of the.

Plots of average estimated and measured GFR vs

Patient selection process in the present study.

Jose R. Garcia et al. BTS 2017;j.jacbts

A, pretreatment CT scan of pelvic lymphadenopathy (identified by white arrow) in 1 patient with documented response to 1α-OH-D2. A, pretreatment CT scan.

Unadjusted means according to normal versus abnormal cardiac variables among current smokers. DD, diastolic dysfunction; LVM, left ventricular mass; RVFAC,

Grayscale ultrasonographic image and resistive index (RI) in severe ischemic acute tubular necrosis. Grayscale ultrasonographic image and resistive index.

Presentation transcript:

Outcomes after two years of ERT in nine Fabry-disease patients with initial normal kidney function Variable Pretreatment Posttreatment P GFR (mL/min) 115±18 102±14 NS Left ventricular posterior wall thickness (mm) 11.7±1.0 10.7±0.7 0.04 Breunig FB et al. Renal Week 2005; November 8-13, 2005; Philadelphia, PA. Poster TH-PO106.

Outcomes after two years of ERT in 16 Fabry-disease patients with initial impaired kidney function Variable Pretreatment Posttreatment p GFR (mL/min) 71±17 60±23 0.04 Left ventricular posterior wall thickness (mm) 14.0±2.1 13.4±2.3 NS Breunig FB et al. Renal Week 2005; November 8-13, 2005; Philadelphia, PA. Poster TH-PO106.